ProCE Banner Activity

Key Slides on Individualized Choices in Antiretroviral Therapy

Slideset Download
Case Challenge
Expert-authored slides covering the latest data and guidelines on patient-centered ART selection for treatment-naive and virologically suppressed patients. Topics include assessing treatment options, individualizing ART for women of childbearing potential and during pregnancy, patients with OIs, and during the COVID-19 pandemic, as well as new data on investigational ART strategies.

Released: November 05, 2021

Expiration: November 04, 2022

No longer available for credit.
Begin Activity

Share

Faculty

Jean-Michel Molina

Jean-Michel Molina, MD, PhD

Head of the Department of Infectious Diseases
Saint-Louis Hospital, Assistance-Publique Hôpitaux de Paris
Paris, France
Professor of Infectious Diseases
University of Paris
Paris, France

Cristina Mussini

Cristina Mussini, MD

Head of Department of Infectious Diseases and Tropical Medicine
Full Professor of Infectious Diseases

Infectious Diseases Clinics, University Hospital
University of Modena and Reggio Emilia
Modena, Italy

Chloe Orkin

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Queen Mary University of London
The Royal London Hospital
London, United Kingdom

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Jean-Michel Molina, MD, PhD

Head of the Department of Infectious Diseases
Saint-Louis Hospital, Assistance-Publique Hôpitaux de Paris
Paris, France
Professor of Infectious Diseases
University of Paris
Paris, France

Jean-Michel Molina, MD, PhD, has disclosed that he has received funds for research support from Gilead Sciences and consulting fees from Bristol-Myers Squibb, Gilead Sciences, Merck, and ViiV Healthcare

Cristina Mussini, MD

Head of Department of Infectious Diseases and Tropical Medicine
Full Professor of Infectious Diseases

Infectious Diseases Clinics, University Hospital
University of Modena and Reggio Emilia
Modena, Italy

Cristina Mussini, MD, has disclosed that she has received consulting fees from AbbVie, Angelini, Gilead Sciences, Janssen, MSD, and ViiV Healthcare and funds for research support from Gilead Sciences, Janssen, MSD, and ViiV Healthcare

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Queen Mary University of London
The Royal London Hospital
London, United Kingdom

Chloe Orkin, MBChB, FRCP, MD, has disclosed that she has received consulting fees, fees for non-CME/CE services, and funds for research support from Gilead Sciences, GlaxoSmithKline, Janssen, MSD, and ViiV Healthcare